{"id":"NCT00097981","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma","officialTitle":"A Randomized, Open-Label, Multi-Center Trial Comparing Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Subjects With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2007-10","completion":"2009-10","firstPosted":"2004-12-02","resultsPosted":"2008-11-27","lastUpdate":"2017-04-07"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Thalidomide","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"DOXIL","otherNames":[]}],"arms":[{"label":"Thalidomide + dexamethasone","type":"ACTIVE_COMPARATOR"},{"label":"Thalidomide + dexamethasone + DOXIL","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if Thalidomide + Dexamethasone or DOXIL (doxorubicin HCl liposome injection) + Thalidomide + Dexamethasone is more effective in treating newly diagnosed patients with multiple myeloma. The number of patients whose multiple myeloma disappears for a period of time (complete Response) will be studied to make the determination of which treatment is more effective.","primaryOutcome":{"measure":"Complete Response Rate: Number of Participants Who Achieved a Complete Response","timeFrame":"From Cycle 2 until 28 days following completion of treatment","effectByArm":[{"arm":"Thalidomide + Dexamethasone","deltaMin":5,"sd":null},{"arm":"DOXIL + Thalidomide + Dexamethasone","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.49"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":58,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":48,"n":110},"commonTop":["Fatigue","Oedema Peripheral","Constipation","Nausea","Anaemia"]}}